Home » Rosetta Genomics Closes on Public Offering, Raises $27.5M

Rosetta Genomics Closes on Public Offering, Raises $27.5M

Aug 08, 2012
|
staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics said today it has closed its public offering, raising $27.5 million in gross proceeds.

The firm offered 5.5 million shares at $5 per share. Aegis Capital was the sole book-running manager for the offering. Rosetta granted the underwriter a 45-day option to purchase up to 825,000 additional shares to cover any overallotments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Drive Resistance

Gene drives might run into biological resistance, the Economist reports.

Dalí DNA Collected

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Synthetic-Conservation Biology Disconnect

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

This Week in Science

In Science this week: full CRISPR locus integration complex structure, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. UC Riverside Team Wins $14.9M DARPA Grant for Genetic Mosquito Control Research

  2. Researchers Design, Construct Genome-Wide Sequence-Verified Arrayed CRISPR Library

  3. Bio-Rad Laboratories Aims to Create Genome Editing Tools Pipeline, Starting With ddPCR

    Premium

  4. Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

  5. Christiana Care, NovellusDx Ink Licensing Deal for Gene-Editing Tech

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.